Skip to content
Are Cheaper Ozempic Knockoffs Safe? episode artwork

Jul 23, 2024 16 min

Are Cheaper Ozempic Knockoffs Safe?

from Big Take Hosted by Bloomberg and iHeartPodcasts

Cheaper, knockoff versions of Ozempic, Wegovy and Zepbound are flooding the market, often promoted by telehealth companies in online ads and by influencers on TikTok and Instagram. These versions of the drugs are made by so-called compounding pharmacies, an obscure corner of America’s pharmaceutical market which makes drugs that aren’t approved by the Food and Drug Administration. On today’s Big Take podcast, Bloomberg reporters Ike Swetlitz and Madison Muller tell host Sarah Holder about their investigation into a $1 billion shadow industry that could be putting Americans’ health in danger. Read more: Unsafe Ozempic Knockoffs Are Flooding the Market

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Are Cheaper Ozempic Knockoffs Safe?

0:00 16:58

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Big Take?

This episode is 16 minutes long.

When was this Big Take episode published?

This episode was published on July 23, 2024.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Big Take episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.